The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials.
Apr 24, 2024
0
0
Clinical trials for cancer drugs have three stages, Phase I–III, before marketing, each with different evaluation items. However, there is no consensus on the appropriateness of evaluation criteria for early-stage clinical ...
Apr 8, 2024
0
0
A team of medical researchers and doctors affiliated with several universities and two hospitals in the U.S. reports that administration of vitamin D2 to patients newly diagnosed with diabetes type 1 can prolong the so-called ...
New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents will facilitate comparisons ...
Oct 20, 2023
0
1
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of ...
Mar 15, 2023
0
23
Researchers from Northumbria University have found that swapping red and processed meat for Quorn's "mycoprotein," a fungi-based meat alternative, leads to a significant reduction in intestinal genotoxins—which can cause ...
Feb 16, 2023
3
17
A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of ...
Dec 10, 2022
0
4455
Change in urinary albumin:creatinine ratio (UACR) and glomerular filtration rate (GFR) slope are markers that are individually used as surrogates of chronic kidney disease progression in clinical trials. Investigators recently ...
Nov 7, 2022
0
9
To ensure all arms in a randomized clinical trial have roughly equal percentages of participants from key subgroups, statisticians often stratify patient assignment to each arm and account for these stratification factors ...
Nov 3, 2022
0
12
